Ireland
--:--IST
Starting soon Not applicable

Study on the Effect of Filters on Discomfort Glare on Healthy Adults

NCT06701981 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-12-02
Last updated
2024-11-22

Condition(s) studied

Glare

Investigational drug(s) / intervention(s)

Filter comparison

Filter comparison: Three filters will be compared on light discomfort thresholds using the Lumiz 100™ device

Study summary

The goal of this clinical trial is to evaluate the glare protection provided by two filters compared to no filter. Using the Lumiz 100™ device (a headset with gradually increasing light), participants will measure their discomfort thresholds under three different conditions (one per filter). Each measurement will be repeated three times. The study requires a single visit of 2 hours for each participant. Glare protection will be quantified by comparing discomfort thresholds across the no-filter condition and the two studied filters.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * A willing person, fluent in French, inclined to follow protocol, capable of reading and understanding the information form, and able to give their free and informed consent. * Beneficiary of the French Social Security system * Aged 18 to 65 years * No or moderate ocular correction (Spherical prescription for distance vision: in the range \[-8.00 to +6.00 D\]\* (negative cylinder) for each eye; Cylindrical prescription for distance vision: in the range \[0 to -4.00 D\] for each eye; Anisometropia ≤ 2.00 D on the equivalent sphere) * Correct vision with prescription glasses (Corrected visual acuity +0.10 logMAR or better (distance vision / high contrast / photopic luminance) * Regular user of sunglasses at least in bright light conditions Exclusion Criteria: * Age \< 18 years (i.e., no minors in accordance with Article L1121-7 of the Public Health Code of "Code de Santé Publique") * Pregnant, parturient, or breastfeeding women (Article L1121-5 of the Public Health Code of "Code de Santé Publique") * Persons deprived of liberty by judicial or administrative decision and persons hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8, and persons admitted to a health or social institution for purposes other than research * Adults incapable or unable to express their consent (Article L1121-8 of the Public Health Code of "Code de Santé Publique") * Participant in the exclusion period of another biomedical research study * Participant who cannot be contacted in case of emergency * All categories of persons particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code) * Employees at the Institut des Sciences de la Vision or EssilorLuxottica * Ocular pathology that may affect vision (e.g., glaucoma involving visual field loss, maculopathy involving visual acuity loss, or retinitis pigmentosa causing significant discomfort in poorly or overly lit environments) * Neurological deficit, including a history of epileptic pathology or regular or severe migraines * Ocular surgery affecting vision (e.g., refractive surgery, cataract surgery, or iridectomy) * Ocular or head trauma

Primary outcome measure(s)

  • Light discomfort thresholds — 2 hours
    Amount of light (in lux) that produce a defined discomfort level (just perceptible or really disturbing)

Trial sites (1)

FacilityCityRegionStatus
Institut des Sciences de la Vision Saint-Etienne France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06701981 on ClinicalTrials.gov ↗ ← All trials in France